Rowlandmiller & Partners’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36M Sell
33,341
-2,979
-8% -$161K 0.43% 54
2026
Q1
$1.9M Sell
36,320
-1,060
-3% -$63.6K 0.38% 56
2025
Q4
$2.2M Hold
37,380
0.42% 55
2025
Q3
$2.08M Sell
37,380
-3,100
-8% -$166K 0.41% 58
2025
Q2
$2.08M Buy
40,480
+600
+2% +$30.1K 0.43% 57
2025
Q1
$2.34M Sell
39,880
-610
-2% -$41.3K 0.49% 50
2024
Q4
$2.92M Sell
40,490
-580
-1% -$42.6K 0.61% 45
2024
Q3
$3.28M Hold
41,070
0.67% 40
2024
Q2
$2.94M Sell
41,070
-6,465
-14% -$476K 0.64% 43
2024
Q1
$3.35M Sell
47,535
-440
-0.9% -$31.5K 0.71% 40
2023
Q4
$3.7M Sell
47,975
-1,160
-2% -$76.4K 0.85% 37
2023
Q3
$3.34M Hold
49,135
0.83% 38
2023
Q2
$4.01M Sell
49,135
-1,010
-2% -$81.2K 0.95% 33
2023
Q1
$3.72M Sell
50,145
-275
-0.5% -$21.2K 0.9% 35
2022
Q4
$4.16M Sell
50,420
-1,860
-4% -$148K 1.03% 32
2022
Q3
$3.71M Hold
52,280
1% 32
2022
Q2
$4.53M Hold
52,280
1.16% 29
2022
Q1
$5.66M Sell
52,280
-3,376
-6% -$348K 1.31% 26
2021
Q4
$7.2M Sell
55,656
-9,952
-15% -$1.22M 1.61% 20
2021
Q3
$4.33M Buy
65,608
+8,020
+14% +$976K 1.47% 22
2021
Q2
$6.48M Sell
57,588
-400
-0.7% -$42.1K 1.59% 20
2021
Q1
$5.54M Sell
57,988
-4,940
-8% -$451K 1.45% 23
2020
Q4
$5M Sell
62,928
-3,080
-5% -$223K 1.42% 23
2020
Q3
$3.13M Buy
66,008
+400
+0.6% +$26K 1.25% 26
2020
Q2
$4.33M Sell
65,608
-400
-0.6% -$24K 1.47% 22
2020
Q1
$3.13M Sell
66,008
-2,800
-4% -$140K 1.25% 26
2019
Q4
$3.78M Buy
68,808
+1,600
+2% +$83.9K 1.17% 30
2019
Q3
$3.33M Sell
67,208
-200
-0.3% -$10K 1.13% 32
2019
Q2
$3.52M Sell
67,408
-960
-1% -$48.4K 1.22% 30
2019
Q1
$3.39M Sell
68,368
-132
-0.2% -$5.94K 1.22% 32
2018
Q4
$2.48M Buy
68,500
+620
+0.9% +$25.9K 1% 34
2018
Q3
$3.46M Sell
67,880
-2,500
-4% -$111K 1.25% 28
2018
Q2
$2.6M Sell
70,380
-600
-0.8% -$22.9K 1.01% 35
2018
Q1
$2.68M Sell
70,980
-8,900
-11% -$314K 1.06% 32
2017
Q4
$2.6M Sell
79,880
-3,344
-4% -$106K 1.02% 31
2017
Q3
$2.62M Sell
83,224
-4,376
-5% -$130K 1.09% 33
2017
Q2
$2.58M Sell
87,600
-2,000
-2% -$54.7K 1.09% 34
2017
Q1
$2.28M Sell
89,600
-500
-0.6% -$12.9K 1% 36
2016
Q4
$2.33M Sell
90,100
-1,460
-2% -$38.4K 1.05% 36
2016
Q3
$2.51M Sell
91,560
-80
-0.1% -$2.2K 1.16% 32
2016
Q2
$2.6M Sell
91,640
-3,120
-3% -$80.2K 1.2% 32
2016
Q1
$2.24M Buy
94,760
+1,280
+1% +$28.2K 1.06% 34
2015
Q4
$2.04M Sell
93,480
-3,040
-3% -$69.3K 1.03% 31
2015
Q3
$2.23M Buy
96,520
+280
+0.3% +$7.02K 1.18% 30
2015
Q2
$2.37M Buy
96,240
+3,320
+4% +$82.9K 1.18% 32
2015
Q1
$2.3M Buy
92,920
+20,220
+28% +$481K 1.14% 33
2014
Q4
$1.68M Buy
+72,700
New +$1.66M 0.81% 37

Other funds holding TECH

Rowlandmiller & Partners's TECH Position: Q2 2026 in Review

Rowlandmiller & Partners reduced its Bio-Techne (TECH) stake by 8.2% in Q2 2026, selling an estimated $161K and leaving 33,341 shares worth $2.36M. The position accounts for 0.43% of the portfolio, ranked #54.

Rowlandmiller & Partners first reported a position in TECH in Q4 2014 and has held it in 47 quarters since. The position peaked at $7.2M in Q4 2021. 186 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Rowlandmiller & Partners held 33,341 shares of Bio-Techne worth $2.36M as of Q2 2026.
  • Rowlandmiller & Partners sold 2,979 Bio-Techne shares in Q2 2026, an estimated $161K.
  • Bio-Techne made up 0.43% of Rowlandmiller & Partners's portfolio in Q2 2026, its #54 holding.
  • Rowlandmiller & Partners first reported a position in Bio-Techne in Q4 2014 and has held it in 47 quarters since.
  • Rowlandmiller & Partners's Bio-Techne position peaked at $7.2M in Q4 2021.
  • 186 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Rowlandmiller & Partners's 13F filing for Q2 2026, filed 23 Jul 2026.